Posts by Admin BioAlps

Artiria Medical raises CHF 3 million to improve stroke treatment   EPFL spin-off, Artiria Medical, is developing micro-actuated catheters and guidewires enabling surgeons to navigate quickly but surely through cerebral arteries. The startup raised CHF 3 million series A from Swiss investors such as 4FO Venture Partners, investiere, Zürcher Kantonal Bank (ZKB), Venture Kick, NEST…

iOnctura raise an additional €5.1 million for their series A funding, reaching a total of €20.1 million   The Geneva-based startup, iOnctura, focuses on clinical stage biopharmaceutical development of different next-generation molecules targeting cancer fibrosis. The startup announced on 14 July 2020 raising another €5.1 million euros from a new investor 3B Future Health Fund,…

EMBION™ Technologies S.A., hard-tech, disruptive innovator in plant-based bioactives for the nutrition of the future, announces the market launch of PREMBION™. It is the first patented product with complex prebiotic properties for animal nutrition that was created with EMBION’s novel platform technology. The spin-off of the Swiss Federal Institute of Technology in Lausanne (EPFL) accelerates nutrition innovation toward increased functionality and greater affordability. It reduces the time from discovery to commercial production by up to 80%. Market introduction tests are currently underway with leading global corporations in the food, feed and drinks sectors.

CoreMedica Europe | A blood test to screen your immune system   The Geneva-based startup has entered the COVID-19 diagnostics race with its own blood test kit. In a record time, CoreMedica Europe has developed and launched on the Swiss market a blood test enabling a full immune system check-up. 3 drops of blood collected…

Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies   On 25 June 2020, Polares Medical SA, a clinical stage medical technology company focused on the development of a unique trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation (MR), announced the closing of a $40 million financing led by…

Unique biosafety laboratory at the University of Bern   On 16 June, the new BSL-3 biosafety laboratory of the University of Bern Institute of Infectious Diseases (IFIK) became operational. The laboratory, based at sitem-insel, is nationally one of the largest and the only BSL-3 laboratory in Switzerland to combine diagnostics, research and translation under one…

CoreMedica Laboratories Inc. provides COVID-19 serology confirmations via a secondary antibody detection method   On 12 June 2020, CoreMedica Laboratories, Inc. announced the implementation of the Roche Elecsys Anti-SARS-CoV-2 antibody test. This new test offers a unique complementary tool to the company’s current high sensitive ELISA method for IgG and IgM antibody detection. CoreMedica is…

HMCare will launch the production of its HelloMask as of early 2021   For the past two years, the EPFL EssentialTech Center and Empa (Swiss federal materials-science center) have collaborated to develop a transparent mask to facilitate communication between caregivers and patients. The startup HMCare, created as a result of this project, has already raised…

GliaPharm reaches a total of CHF 2 million raised to further its drug development   On 25 May 2020, EPFL spin-off, GliaPharm announced raising CHF 1.5 million bringing its total investment to CHF 2 million. The Geneva-based startup will use these new funds to further the development of its drug against the rare targeted metabolic…

BioAlps Networking Day 2020 | Annual gathering of Western Switzerland’s Life Sciences’ Community   The event is planned to take place on 9 November 2020 at the SwissTech Convention Center in Lausanne. The BioAlps team is monitoring the evolution of the situation linked to the new coronavirus to ensure that the format of our event,…